Filed: 11/14/2022ACC: 0001214659-22-013603
📋 What this filing means
SIO CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 49 equity positions with a total reported market value of $314.7K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
49
Positions
$314.7K
Total AUM (reported)
24.71M
Total Shares
Allocation by class
COM$198.1K62.9%
SPONSORED ADS$39.2K12.4%
CL A SHS$23.0K7.3%
COMMON STOCK$14.8K4.7%
SPONSORED ADR$13.6K4.3%
COM CL A$8.0K2.5%
SPDN ADR NEW$5.3K1.7%
Portfolio Concentration
Top 3$96.2K30.6%
4–10$123.8K39.3%
11–25$76.0K24.1%
Rest$18.7K6.0%
Top 3 weight
30.6%
Top 10 weight
69.9%
Voting Authority Distribution
Total shares with voting rights: 24.71M
Sole
Full voting authority
24.71M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole48
Shared0
Other1
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings49
Rows:
AMERISOURCEBERGEN CORP
SOLEShares282.40K
TypeSH
Market value$38.2K
12.14%
Sole
282.40K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares507.70K
TypeSH
Market value$34.7K
11.02%
Sole
507.70K
Shared
0.00
None
0.00
GSK PLC
SOLEShares790.60K
TypeSH
Market value$23.3K
7.39%
Sole
790.60K
Shared
0.00
None
0.00
MEDICUS SCIENCES ACQUISITION
DFNDShares2.32M
TypeSH
Market value$23.0K
7.31%
Sole
2.32M
Shared
0.00
None
0.00
RELMADA THERAPEUTICS INC
SOLEShares606.20K
TypeSH
Market value$22.4K
7.13%
Sole
606.20K
Shared
0.00
None
0.00
PROMETHEUS BIOSCIENCES INC
SOLEShares332.20K
TypeSH
Market value$19.6K
6.23%
Sole
332.20K
Shared
0.00
None
0.00
BICYCLE THERAPEUTICS PLC
SOLEShares683.42K
TypeSH
Market value$15.9K
5.05%
Sole
683.42K
Shared
0.00
None
0.00
ORGANON & CO
SOLEShares628.84K
TypeSH
Market value$14.7K
4.68%
Sole
628.84K
Shared
0.00
None
0.00
CIGNA CORP
SOLEShares52.61K
TypeSH
Market value$14.6K
4.64%
Sole
52.61K
Shared
0.00
None
0.00
SANOFI SA
SOLEShares356.89K
TypeSH
Market value$13.6K
4.31%
Sole
356.89K
Shared
0.00
None
0.00
INOGEN INC
SOLEShares521.29K
TypeSH
Market value$12.7K
4.02%
Sole
521.29K
Shared
0.00
None
0.00
CENTENE CORP DEL
SOLEShares127.01K
TypeSH
Market value$9.9K
3.14%
Sole
127.01K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP
SOLEShares44.96K
TypeSH
Market value$9.4K
2.99%
Sole
44.96K
Shared
0.00
None
0.00
THE BEAUTY HEALTH CO
SOLEShares658.96K
TypeSH
Market value$7.8K
2.47%
Sole
658.96K
Shared
0.00
None
0.00
SMITH & NEPHEW PLC
SOLEShares228.39K
TypeSH
Market value$5.3K
1.69%
Sole
228.39K
Shared
0.00
None
0.00
VANDA PHARMACEUTICALS INC
SOLEShares488.96K
TypeSH
Market value$4.8K
1.54%
Sole
488.96K
Shared
0.00
None
0.00
POINT BIOPHARMA GLOBAL INC
SOLEShares544.54K
TypeSH
Market value$4.2K
1.34%
Sole
544.54K
Shared
0.00
None
0.00
INARI MEDICAL INC
SOLEShares57.47K
TypeSH
Market value$4.2K
1.33%
Sole
57.47K
Shared
0.00
None
0.00
UNIVERSAL HEALTH SERVICES INC
SOLEShares40.73K
TypeSH
Market value$3.6K
1.14%
Sole
40.73K
Shared
0.00
None
0.00
EUCRATES BIOMEDICAL ACQUISITION CORP.
SOLEShares248.67K
TypeSH
Market value$2.5K
0.79%
Sole
248.67K
Shared
0.00
None
0.00
HEALTH SCIENCES ACQUISITIONS CORP 2
SOLEShares250K
TypeSH
Market value$2.5K
0.79%
Sole
250K
Shared
0.00
None
0.00
AEGLEA BIO THERAPEUTICS INC
SOLEShares4.67M
TypeSH
Market value$2.5K
0.78%
Sole
4.67M
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares1.42M
TypeSH
Market value$2.4K
0.77%
Sole
1.42M
Shared
0.00
None
0.00
MODULAR MEDICAL INC
SOLEShares574.35K
TypeSH
Market value$2.4K
0.75%
Sole
574.35K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares555.61K
TypeSH
Market value$1.9K
0.62%
Sole
555.61K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AMERISOURCEBERGEN CORPSOLE | COM | 282.40K | SH | $38.2K 12.14% | 282.40K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 507.70K | SH | $34.7K 11.02% | 507.70K | 0.00 | 0.00 |
GSK PLCSOLE | SPONSORED ADS | 790.60K | SH | $23.3K 7.39% | 790.60K | 0.00 | 0.00 |
MEDICUS SCIENCES ACQUISITIONDFND | CL A SHS | 2.32M | SH | $23.0K 7.31% | 2.32M | 0.00 | 0.00 |
RELMADA THERAPEUTICS INCSOLE | COM | 606.20K | SH | $22.4K 7.13% | 606.20K | 0.00 | 0.00 |
PROMETHEUS BIOSCIENCES INCSOLE | COM | 332.20K | SH | $19.6K 6.23% | 332.20K | 0.00 | 0.00 |
BICYCLE THERAPEUTICS PLCSOLE | SPONSORED ADS | 683.42K | SH | $15.9K 5.05% | 683.42K | 0.00 | 0.00 |
ORGANON & COSOLE | COMMON STOCK | 628.84K | SH | $14.7K 4.68% | 628.84K | 0.00 | 0.00 |
CIGNA CORPSOLE | COM | 52.61K | SH | $14.6K 4.64% | 52.61K | 0.00 | 0.00 |
SANOFI SASOLE | SPONSORED ADR | 356.89K | SH | $13.6K 4.31% | 356.89K | 0.00 | 0.00 |
INOGEN INCSOLE | COM | 521.29K | SH | $12.7K 4.02% | 521.29K | 0.00 | 0.00 |
CENTENE CORP DELSOLE | COM | 127.01K | SH | $9.9K 3.14% | 127.01K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORPSOLE | COM | 44.96K | SH | $9.4K 2.99% | 44.96K | 0.00 | 0.00 |
THE BEAUTY HEALTH COSOLE | COM CL A | 658.96K | SH | $7.8K 2.47% | 658.96K | 0.00 | 0.00 |
SMITH & NEPHEW PLCSOLE | SPDN ADR NEW | 228.39K | SH | $5.3K 1.69% | 228.39K | 0.00 | 0.00 |
VANDA PHARMACEUTICALS INCSOLE | COM | 488.96K | SH | $4.8K 1.54% | 488.96K | 0.00 | 0.00 |
POINT BIOPHARMA GLOBAL INCSOLE | COM | 544.54K | SH | $4.2K 1.34% | 544.54K | 0.00 | 0.00 |
INARI MEDICAL INCSOLE | COM | 57.47K | SH | $4.2K 1.33% | 57.47K | 0.00 | 0.00 |
UNIVERSAL HEALTH SERVICES INCSOLE | CL B | 40.73K | SH | $3.6K 1.14% | 40.73K | 0.00 | 0.00 |
EUCRATES BIOMEDICAL ACQUISITION CORP.SOLE | UNIT 10/23/2027 | 248.67K | SH | $2.5K 0.79% | 248.67K | 0.00 | 0.00 |
HEALTH SCIENCES ACQUISITIONS CORP 2SOLE | ORD SHS | 250K | SH | $2.5K 0.79% | 250K | 0.00 | 0.00 |
AEGLEA BIO THERAPEUTICS INCSOLE | COM | 4.67M | SH | $2.5K 0.78% | 4.67M | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM | 1.42M | SH | $2.4K 0.77% | 1.42M | 0.00 | 0.00 |
MODULAR MEDICAL INCSOLE | COM NEW | 574.35K | SH | $2.4K 0.75% | 574.35K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 555.61K | SH | $1.9K 0.62% | 555.61K | 0.00 | 0.00 |
Page 1 of 2